Cardiovascular Systems treats first patients using Propel pVAD

Cardiovascular Systems (Nasdaq:CSII) today announced the first in-human procedures using its Propel percutaneous ventricular assist device.

The first patients were treated at Piedmont Heart Institute and Cardiovascular Services in Tbilisi, Georgia by Dr. David Kandzari. The St. Paul, Minnesota-based company reported that Propel performed as intended and provided uninterrupted hemodynamic support leading to successful revascularization.

Get the full story on our sister site, Medical Tubing + Extrusion.

Original Article: (https://www.massdevice.com/cardiovascular-systems-treats-first-patients-using-propel-pvad/)